EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine

Elisa Longhitano iD, Paola Muscolino, Claudia Lo Re, Serena Ausilia Ferrara, Valeria Cernaro iD, Guido Gembillo iD, Dalila Tessitore, Desirèe Speranza iD, Francesco Figura, Mariacarmela Santarpia, Nicola Silvestris, Domenico Santoro iD und 1 weitere

Cancers · 21.03.2023 · 15 (6) · 1891

DOI: 10.3390/cancers15061891 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 21.03.2023. Verfasst von Elisa Longhitano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Nephrology and Dialysis, Department of Clinical and Experimental Medicine, A.O.U. "G. Martino", University of Messina, 98125 Messina, Italy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunity plays a crucial role in fighting cancer, but tumours can evade the immune system and proliferate and metastasize. Enhancing immune responses is a new challenge in anticancer therapies. In this context, efficacy data are accumulating on immune checkpoint inhibitors and adjuvant therapies for various types of advanced-stage solid tumours. Unfortunately, immune-related adverse events are common. Although infrequent, renal toxicity may occur via several mechanisms and may require temporary or permanent drug suspension, renal biopsy, and/or immunosuppressive treatment. This short review aims to provide a practical approach to the multidisciplinary management of cancer patients with renal toxicity during treatment with immune checkpoint inhibitors.

Schlagwörter

Stichwörter der Autor:innen

AKI-ICICTLA-4ICIsPD-1cancerimmune checkpoint inhibitorsirAE

Autor:innen und Institutionen

  • Unit of Nephrology and Dialysis, Department of Clinical and Experimental Medicine, A.O.U. "G. Martino", University of Messina, 98125 Messina, Italy.
  • Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, 98125 Messina, Italy.

ORCID-Profile: Elisa Longhitano, Valeria Cernaro, Guido Gembillo, Desirèe Speranza, Domenico Santoro

Zitieren

APA

Longhitano, E., Muscolino, P., Lo Re, C., Ferrara, S. A., Cernaro, V., Gembillo, G., Tessitore, D., Speranza, D., Figura, F., Santarpia, M., Silvestris, N., Santoro, D., & Franchina, T. (2023). Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine. Cancers, 15(6), 1891. https://doi.org/10.3390/cancers15061891

Vancouver

Longhitano E, Muscolino P, Lo Re C, Ferrara SA, Cernaro V, Gembillo G, et al. Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine. Cancers. 2023;15(6):1891. doi:10.3390/cancers15061891

BibTeX
@article{Longhitano2023,
  author = {Longhitano, Elisa and Muscolino, Paola and Lo Re, Claudia and Ferrara, Serena Ausilia and Cernaro, Valeria and Gembillo, Guido and Tessitore, Dalila and Speranza, Desirèe and Figura, Francesco and Santarpia, Mariacarmela and Silvestris, Nicola and Santoro, Domenico and Franchina, Tindara},
  title = {Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1891},
  doi = {10.3390/cancers15061891}
}
Kostenlos starten →